The Think Tank on Advancing Precision Medicine in Rare Cancers is a highly interactive meeting that brings together clinicians, researchers, industry representatives, advocates, and patients to collaborate on common challenges in rare cancer research and treatment.
Leveraging the successful Think Tank model established through over a decade of TargetCancer Foundation meetings, it creates a collaborative environment where diverse perspectives and ideas thrive. This meeting also builds on the progress made through TargetCancer Foundation’s TCF-001 TRACK study, a nationwide, decentralized, patient-driven clinical trial studying precision medicine in rare cancers.
2025 Think Tank on Advancing Precision Medicine in Rare Cancers
October 29, 2025 | State Room, Boston, MA
8:00 AM- 5:00 PM
Reception and poster session to follow
*Please note that this meeting is being held in-person only- there is no option to participate virtually.
Call for Abstracts
Encouraging Early Career Investigators to Make a Difference in Rare Cancers
TargetCancer Foundation is pleased to invite early investigators from universities, medical, and scientific institutions to submit abstracts for the upcoming Think Tank. Abstract topics must be on research focused on rare cancers, including but not limited to clinical, translational, epidemiological, and basic science studies.
The submission deadline is August 4, 2025.
Agenda
Scientific Keynote Speaker
Dr. Andrea Cercek
Section Head, Colorectal Cancer
Co-Director, Center for Young Onset Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Venue
The 2025 Think Tank on Advancing Precision Medicine in Rare Cancers will be held at the State Room, located at 60 State Street in Boston, MA. The venue is centrally located downtown and easily accessible via public transport.
Accommodations
We have secured a room block for attendees at The Bostonian Hotel for the nights of Tuesday, October 28 and Wednesday, October 29. We are pleased to offer a discounted rate of $309/night + tax*. The Bostonian is a five-minute walk to the meeting venue.
Please click here to secure a room in our block.
The block will close on Tuesday, September 30, 2025.
* Please note that your total will be $360/night after taxes. A destination fee that is required to be included at the time of booking will be waived prior to checkout.
Thank You To Our Sponsors
What participants are saying
This was a fantastic #RareCancer #PrecisionMedicine meeting @targetcancer in Boston! So much enthusiasm from patients and patient advocates to move the field forward.
Vivek Subbiah, MD
Sarah Cannon Research Institute
Originally posted on Twitter
This is genuinely the best rare cancer meeting I have ever attended.
Razelle Kurzrock, MD
Froedtert and Medical College of Wisconsin
…thank you for allowing me to be a part of the discussion of challenges, goals, opportunities and best practices in addressing the needs of patients facing rare cancers. What a wonderful group of humans you gathered. I was so inspired.
Katie Ortman Doble
Patient Keynote Speaker,
2023 Think Tank on Advancing Precision Medicine in Rare Cancers
View and download materials from past meetings
TCF-001 TRACK Live Molecular Tumor Board 2024:
Salivary Duct Carcinoma
Presented at the TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers, November 20, 2024, Boston MA
We are grateful to our industry partners for supporting these meetings and for their dedication to developing treatments for patients with rare cancers.